Drug information for BUTAZOLIDIN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
100MG
Discontinued
PHENYLBUTAZONE
Phenylbutazone
NOVARTIS
8319
TABLET; ORAL
100MG
Discontinued
PHENYLBUTAZONE
Phenylbutazone
NOVARTIS
"
Drug Adverse Effects information for BUTAZOLIDIN
Role code
Indications
Reaction
# Reports
C
ANAESTHESIA
ANXIETY
1
C
ANAESTHESIA
ARRHYTHMIA SUPRAVENTRICULAR
1
C
ANAESTHESIA
IMPETIGO HERPETIFORMIS
1
C
ANAESTHESIA
PRINZMETAL ANGINA
1
C
ANKYLOSING SPONDYLITIS
CROHN'S DISEASE
1
C
ANKYLOSING SPONDYLITIS
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
ANKYLOSING SPONDYLITIS
WEIGHT DECREASED
1
C
INTERMITTENT CLAUDICATION
DIABETES MELLITUS INADEQUATE CONTROL
1
C
INTERMITTENT CLAUDICATION
SINUS TACHYCARDIA
1
C
MUSCULOSKELETAL PAIN
ANXIETY
2
C
MUSCULOSKELETAL PAIN
ARRHYTHMIA SUPRAVENTRICULAR
2
C
MUSCULOSKELETAL PAIN
IMPETIGO HERPETIFORMIS
2
C
MUSCULOSKELETAL PAIN
PRINZMETAL ANGINA
2
C
NEPHROLITHIASIS
ANXIETY
1
C
NEPHROLITHIASIS
ARRHYTHMIA SUPRAVENTRICULAR
1
C
NEPHROLITHIASIS
IMPETIGO HERPETIFORMIS
1
C
NEPHROLITHIASIS
PRINZMETAL ANGINA
1
C
PAIN
ANXIETY
1
C
PAIN
ARRHYTHMIA SUPRAVENTRICULAR
1
C
PAIN
IMPETIGO HERPETIFORMIS
1
C
PAIN
PRINZMETAL ANGINA
1
C
PERIOSTITIS
ANXIETY
1
C
PERIOSTITIS
ARRHYTHMIA SUPRAVENTRICULAR
1
C
PERIOSTITIS
IMPETIGO HERPETIFORMIS
1
C
PERIOSTITIS
PRINZMETAL ANGINA
1
C
PROSTATIC ADENOMA
CROHN'S DISEASE
2
C
PROSTATIC ADENOMA
GENERAL PHYSICAL HEALTH DETERIORATION
2
C
PROSTATIC ADENOMA
WEIGHT DECREASED
2
C
SPONDYLITIS
CROHN'S DISEASE
1
C
SPONDYLITIS
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
SPONDYLITIS
WEIGHT DECREASED
1
Ads by Google